These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 6356523)
1. Antithymocyte globulin as the primary treatment for renal allograft rejection. Nelson PW; Cosimi AB; Delmonico FL; Rubin RH; Tolkoff-Rubin NE; Fang L; Russell PS Transplantation; 1983 Nov; 36(5):587-9. PubMed ID: 6356523 [No Abstract] [Full Text] [Related]
2. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation. Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109 [TBL] [Abstract][Full Text] [Related]
3. Monitoring antithymocyte globulin in renal transplantation. Clark K Ann R Coll Surg Engl; 1996 Nov; 78(6):536-40. PubMed ID: 8943640 [No Abstract] [Full Text] [Related]
5. [Polyclonal rabbit antithymocyte globulin (thymoglobulin): immunomodulatory effects and new aspects of its clinical application]. Kulagin AD; Lisukov IA; Miloserdov IA; Afanas'ev BV Ter Arkh; 2010; 82(7):65-72. PubMed ID: 20853613 [TBL] [Abstract][Full Text] [Related]
6. Reversal of acute renal allograft rejection with adjunctive AG therapy. Filo RS; Smith EJ; Leapman SB Transplant Proc; 1981 Mar; 13(1 Pt 1):482-90. PubMed ID: 7022879 [TBL] [Abstract][Full Text] [Related]
7. The adjunctive value of equine antithymocyte membrane globulin in a randomized study of patients undergoing cadaveric renal transplantation. Diethelm AG; Blackstone E; Whelchel JD; Pass RF; Chambers L; Phillips SJ; Thiry C Transplant Proc; 1979 Mar; 11(1):27-30. PubMed ID: 377644 [No Abstract] [Full Text] [Related]
8. Uses of antilymphocyte globulin in renal transplantation. Novick AC Urol Clin North Am; 1983 May; 10(2):253-62. PubMed ID: 6344386 [No Abstract] [Full Text] [Related]
9. Use of antithymocyte globulin for reversal of acute allograft rejection. Shield CF; Cosimi AB; Tolkoff-Rubin N; Rubin RH; Herrin J; Russell PS Transplantation; 1979 Dec; 28(6):461-4. PubMed ID: 390784 [No Abstract] [Full Text] [Related]
10. Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation. Kitabayashi K; Munn SR; Sterioff S Transplant Proc; 1996 Jun; 28(3):1973-5. PubMed ID: 8658964 [No Abstract] [Full Text] [Related]
11. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection. Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569 [TBL] [Abstract][Full Text] [Related]
12. The high failure rate of OKT3 in the treatment of acute renal allograft rejection resistant to steroids with or without antithymocyte globulin. Davies SP; Brown EA; Woodrow DF; Phillips ME; Gower PE; Mee AD Transplantation; 1991 Oct; 52(4):746-9. PubMed ID: 1926361 [No Abstract] [Full Text] [Related]
13. Graft mucormycosis in a renal allograft recipient. Ahmad M J Nephrol; 2005; 18(6):783-6. PubMed ID: 16358241 [TBL] [Abstract][Full Text] [Related]
14. The use of antilymphoblast globulin in the treatment of renal allograft rejection. Howard RJ; Condie RM; Sutherland DE; Simmons RL; Najarian JS Transplant Proc; 1981 Mar; 13(1 Pt 1):473-4. PubMed ID: 7022876 [No Abstract] [Full Text] [Related]